Listed

Foghorn Therapeutics Inc.: Form 10-Q for the period ended Sep 30, 2020

Filed with the SEC on Dec 4, 2020 and accepted by EDGAR at Dec 4, 2020, 16:51 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2020-09-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2020-07-01 to 2020-09-30$179.0kus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Revenue9 months2020-01-01 to 2020-09-30$179.0kus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Research and development3 months2020-07-01 to 2020-09-30$16.1mus-gaap:ResearchAndDevelopmentExpense
Research and development9 months2020-01-01 to 2020-09-30$41.2mus-gaap:ResearchAndDevelopmentExpense
Operating income3 months2020-07-01 to 2020-09-30−$18.5mus-gaap:OperatingIncomeLoss
Operating income9 months2020-01-01 to 2020-09-30−$47.8mus-gaap:OperatingIncomeLoss
Interest expense3 months2020-07-01 to 2020-09-30$202.0kus-gaap:InterestExpense
Interest expense9 months2020-01-01 to 2020-09-30$658.0kus-gaap:InterestExpense
Net income3 months2020-07-01 to 2020-09-30−$18.4mus-gaap:NetIncomeLoss
Net income9 months2020-01-01 to 2020-09-30−$48.0mus-gaap:NetIncomeLoss
Operating cash flow9 months2020-01-01 to 2020-09-30−$20.6mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure9 months2020-01-01 to 2020-09-30$8.7mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2020-09-30$74.6mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2020-09-30$77.8mus-gaap:AssetsCurrent
Total assetsAt period end2020-09-30$142.4mus-gaap:Assets
Current liabilitiesAt period end2020-09-30$21.3mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2020-09-30$99.3mus-gaap:Liabilities
Long-term debtAt period end2020-09-30$8.8mus-gaap:LongTermDebtNoncurrent
Current portion of debtAt period end2020-09-30$6.0mus-gaap:LongTermDebtCurrent
Shareholders' equityAt period end2020-09-30−$133.3mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001193125-20-310715. Last ingested by Listed: Nov 9, 2026, 17:27 ET. Listed shows no prices and gives no investment advice.